View a ticker or compare two or three
STOK
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

STOK is expected to report earnings to fall 6.40% to -53 cents per share on August 05

Stoke Therapeutics STOK Stock Earnings Reports
Q2'24
Est.
$-0.53
Q1'24
Beat
by $0.05
Q4'23
Beat
by $0.04
Q3'23
Beat
by $0.08
Q2'23
Missed
by $0.06
The last earnings report on May 06 showed earnings per share of -56 cents, beating the estimate of -62 cents. With 263.13K shares outstanding, the current market capitalization sits at 707.80M.
A.I. Advisor
published General Information

General Information

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIEKX27.50N/A
N/A
Pioneer International Equity K
RGDTX10.45-0.07
-0.67%
Russell Inv Global Equity M
JENIX63.62-0.48
-0.75%
Jensen Quality Growth I
RIVBX33.04-0.30
-0.90%
Riverbridge Growth Institutional
FVLCX22.06-0.26
-1.16%
Fidelity Advisor Value Leaders C

STOK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with NUVB. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
-0.37%
NUVB - STOK
47%
Loosely correlated
-6.19%
INZY - STOK
46%
Loosely correlated
-7.32%
QTTB - STOK
45%
Loosely correlated
+6.28%
STRO - STOK
44%
Loosely correlated
-8.37%
KOD - STOK
42%
Loosely correlated
-0.33%
More